Visit ViVitro Labs Inc. in booth 1136, October 27-November 1, 2013, at the TCT 2013 Conference in San Francisco, CA. ViVitro Labs staff members will showcase industry leading prosthetic heart valve test equipment. Experts will be on hand to discuss laboratory testing, consulting and engineering services. Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine.
TCT showcases the latest advances in current therapies and clinical research and our long-standing commitment to life-saving innovation to translate into improved patient care.
About ViVitro Labs Inc.
ViVitro Labs Inc. offers industry-leading cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 39 countries for 25+ years have trusted ViVitro expertise, accuracy, and quality for their heart valve, LVAD, TAH, stent, and graft testing.
ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. ViVitro products are manufactured by StarFish Medical. ViVitro’s A2LA Scope of Accreditation includes the physical and mechanical testing of heart valve substitutes.